These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26129643)

  • 1. Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum.
    Chen JJ; Liu TC; Liang QN; Dong ZN; Wu YS; Li M
    J Med Virol; 2015 Nov; 87(11):1940-5. PubMed ID: 26129643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum.
    Chen J; Liu T; Chen Z; Hou J; Wu Y; Li M
    Viral Immunol; 2015 Apr; 28(3):179-83. PubMed ID: 25651045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a time-resolved fluoroimmunoassay for Epstein-Barr virus viral capsid antigen IgA antibody in human serum.
    Liang QN; Chen PQ; Liu TC; Zhou JW; Chen JJ; Wu YS
    J Virol Methods; 2015 Sep; 222():16-21. PubMed ID: 25977184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
    Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
    Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients.
    Ayadi W; Karray-Hakim H; Feki L; Khabir A; Boudawara T; Ghorbel A; Daoud J; Frikha M; Hammami A
    J Med Virol; 2009 Aug; 81(8):1412-21. PubMed ID: 19551836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on sero-diagnosis of nasopharyngeal carcinoma using a dual antibody test against recombinant Epstein-Barr virus antigens.
    Gu YL; Zhang CQ; Ng SP; Zong YS; Liang YJ; Chen YL
    Ai Zheng; 2003 Sep; 22(9):903-6. PubMed ID: 12969518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of serum Epstein-Barr virus antibody level by ELISA in normal populations and nasopharyngeal carcinoma patients in Zhongshan City of China].
    Cheng MT; Cheng WM; Ji MF; Liang JS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):817-8, 822. PubMed ID: 12297441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood.
    Schaade L; Kleines M; Häusler M
    J Clin Microbiol; 2001 Nov; 39(11):3902-5. PubMed ID: 11682505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma.
    Jiang SQ; Liu Q
    Ai Zheng; 2009 Feb; 28(2):177-80. PubMed ID: 19550133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies.
    Liang QN; Zhou JW; Liu TC; Lin GF; Dong ZN; Chen ZH; Chen JJ; Wu YS
    Luminescence; 2015 Aug; 30(5):649-54. PubMed ID: 25377426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
    Cai YL; Zheng YM; Cheng JR; Wang W; Zhang YN; Wang WH; Wu YS; Zhong WM; Li J; Mo YK
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
    Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein-Barr virus serologic status.
    Devanthéry O; Meylan P
    Clin Microbiol Infect; 2010 Dec; 16(12):1776-82. PubMed ID: 20219083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific IgA antibodies to recombinant early and nuclear antigens of Epstein-Barr virus in nasopharyngeal carcinoma.
    Hsu MM; Hsu WC; Sheen TS; Kao CL
    Clin Otolaryngol Allied Sci; 2001 Aug; 26(4):334-8. PubMed ID: 11559349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization.
    Liu Z; Yu KJ; Coghill AE; Brenner N; Cao SM; Chen CJ; Chen Y; Doolan DL; Hsu WL; Labo N; Middeldorp JM; Miley W; Simon J; Wang CP; Waterboer T; Whitby D; Xie SH; Ye W; Hildesheim A
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.